As E-cadherin contacts suppress EGFR/ERK signalling in urothelial cells, the implication is that E-cadherin loss may directly contribute to the activation of RTKs frequently reported in carcinomas [32], including those of the bladder ([33] and references therein). The gene discussed is CDH1; the disease is carcinoma.